NPI Lens

Rajat Bhushan

NPI 1881709657ActiveIndividual· Specialist· Baton Rouge, LA

Specialist in Baton Rouge, Louisiana, licensed in LA, with an NPI issued in August 2006. Part D covered 4,788 prescriptions written in 2024, 68% of them generic. Novo Nordisk Inc was the largest of 2 companies reporting payments in 2025, $81.32 in all, mostly food and beverage.

Overview

NPI1881709657
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedAug 20, 2006
Last updated in NPPESJan 14, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Specialist Primary174400000XMD.07843RLA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (LA)

Part D prescriptions in 2024

Prescriptions (claims)4,788 · 8,335 30-day fills
Patients133
Total drug cost$1,099,104
Generic share68% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$81.32 · 2 payments from 2 companies
  • 2024$104.71 · 6 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$56.091
Takeda Pharmaceuticals U.S.A., Inc.$25.231

What the 2025 payments were for

  • Food and Beverage$81.32 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Baton Rouge

All Specialist providers in Louisiana →